Patent Assignment
Reel/Frame 066718/0331
Security Interest
Recorded: 2024-03-11
Pages: 7
Assignor
SERES THERAPEUTICS, INC.
Executed: 2024-03-07
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FL., LOS ANGELES, CALIFORNIA, 90071
Covered Properties
(4)
Use of Designed Bacterial Compositions for Infection Treatment
PCT:
PCT/US2024/013624 ↗
Synergistic Bacterial Compositions and Methods of Production and Use Thereof
Methods of Populating a Gastrointestinal Tract
Application:
18/431,885 →
Publication:
US 2025/0000915
Manipulation of Tryptamine Metabolism
Application:
18/532,577 →
Publication:
US 2025/0017984
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 4, 2025
From: HENN, MATTHEW R.; LITCOFSKY, KEVIN DANIEL; D'ONOFRIO, ANTHONY MARIO; OHSUMI, TOSHIRO K.
To: SERES HEALTH, INC.
Reel/Frame 071924/0799 →
Security Interest
Aug 4, 2025
From: SERES THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071925/0410 →
Release of Security Interest
Aug 4, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: SERES THERAPEUTICS, INC.
Reel/Frame 071926/0236 →
Change of Name
Aug 4, 2025
From: SERES HEALTH, INC.
To: SERES THERAPEUTICS, INC.
Reel/Frame 072345/0841 →
Cross-License Agreement
Mar 30, 2026
From: SERES THERAPEUTICS, INC.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 075314/0554 →